跳至主要内容
临床试验/NCT05241496
NCT05241496Unknown不适用

Lidocaine Spray 10% Versus Oral Ibuprofen Tablets in Pain Control During Copper Intrauterine Device Insertion (A Randomized Controlled Trial)

Marina Ramsis Aziz Ghaly2 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2021年12月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1
试验地点
2
主要终点
Self-reported pain score [ Time Frame: immediately after IUD insertion ]

研究概览

简要总结

The intrauterine contraceptive device (IUD) is the most commonly used form of reversible contraception worldwide; the predominant type of product, the copper IUD (a plastic T-shaped device with copper affixed to it) was developed over 30 years ago and has become the standard bearer for intrauterine contraception, due to its long-term effectiveness, safety and affordability .

Inconsistent use and discontinuation of contraceptives are major causes of unintended pregnancy . The failure rate of the patch or ring is 20 times higher than that of long acting reversible contraceptives (LARCs) . Increasing acceptability and use of LARC methods like the intrauterine device (IUD) is an important strategy to reduce the risk of unintended pregnancy

详细描述

The aim of this study is to This study is designed to compare between lidocaine spray 10% and oral ibuprofen as an adequate method for decreasing pain during copper intrauterine contraceptive device insertion .

Research question:

Which of both drugs ( local lidocaine spray 10% or oral ibuprofen tab.) is more effective in decreasing pain during IUD insertion ? Research Hypothesis In this current study, we hypothesize that using of local cervical lidocaine spray 10% prior to IUD insertion will decrease the pain more effectively than ibuprofen tablet 400 mg.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Multiparous women in 3rd to 5th day of menstrual cycle 2- Women who were 6 weeks postpartum or if recently pregnant. 3- Accept to participate and provide consent

排除标准

  • • A contraindication for IUD use such as a gynecological malignancy , sexually transmitted diseases, pelvic inflammatory disease or undiagnosed abnormal vaginal bleeding.
  • Suspicion of pregnancy .
  • Allergy to lidocaine or ibuprofen .
  • Copper allergy .
  • Any uterine abnormalities distorted uterine cavity as congenital anomalies, endometrial lesions, adenomyosis , and submucous myoma.
  • A psychological or neurological disorder associated with altered pain sensation.
  • MIRENA insertion.
  • Nulliparity.
  • History of failed intrauterine device insertion (uterine perforation, acute expulsion).

结局指标

主要结局

Self-reported pain score [ Time Frame: immediately after IUD insertion ]

时间窗: immediately after IUD insertion

The visual analog scale (VAS ) pain score reported by participants immediately after IUD insertion .Pain scores will be measured using a visual analogue scale (VAS) consisting of a 10 cm horizontal straight line on which 0 cm corresponds to no pain and 10 cm to the worst pain. VAS is rated as 0 for no pain, 1-3 for mild pain, 4-6 for average pain, and 7-9 for severe pain and 10 for extremely severe pain an individual can experience . A research assistant standing beside the woman will hold the VAS sheet for the participant to select the point that corresponds to the level of pain she will experience after IUD insertion .

次要结局

  • Immediate complications related to IUD insertion [ Time Frame: one day after insertion]:(one day after insertion)

研究者

发起方
Marina Ramsis Aziz Ghaly
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Marina Ramsis Aziz Ghaly

principal investigator

Ain Shams University

研究点 (2)

Loading locations...

相似试验

Lidocaine Spray 10% Versus Oral Ibuprofen Tablets in... | 临床试验